脂联素与冠心病及其危险因素关系的研究进展
被引量:7
摘要
脂联素是脂肪细胞分泌的脂肪因子之一,与代谢综合征的各组分关系密切,成为近来研究的热点。本文就脂联素与冠心病及其危险因素关系的最新研究进展进行综述。
出处
《中国动脉硬化杂志》
CAS
CSCD
2008年第2期158-160,共3页
Chinese Journal of Arteriosclerosis
参考文献22
-
1Schever PE, williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to Clq, produced exclusively in adipocytes [J]. ] Biol Chem,1995, 270 (45): 26746-749.
-
2Aftra Y, Kihara S, Ouchi N, Takshashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein,adiponectin,inobesity[J].Biochem Biophys Res Commun. 1999, 257 (1): 79-83.
-
3Maeda K,Okubo K,Shimomura I,Funahashi T,Matsuzawa Y,Matsubara K.cDNA cloning and expression of an novel adipose -specific collagen-like factor apM1 (sdipose most abundant gene transcript1)[J].Biochem Biophys Res Commun.1996,221(2):286-289.
-
4Hara K, Boutin P, Mini Y, Tobe K, Dina C, Yasuda K, et al. Genetic variation in the gene encoding adiponectin is associated with an incressed risk of type 2 diabetes in the Japanese Population [ J]. Diabetes, 2902, 51 (2) : 536-540.
-
5Aso Y,Yamamoto R,Wakabayashi S,Uchida T,Taksyanagi K,Takebayashi K,et al.Comparison of serum high-molecular weight(HMW)adiponectin with total adiponectin concentrations in type 2diabetic patients with coronary artery disease using a novel erzyme-linked immunosorbent assay to detect HMW adiponectin [J].Diabetes,2006,55(7):1954-960.
-
6Shimabukuro M,Higa N,Asshi T,Oshiro Y,Takasu N,Tagawa T,et al.Hypoadiponectinemia is closely linked to endothelial dysfunction in man[J].J Clin Endocrinol Metab,2003,88(7):3236-240.
-
7Okamoto Y,Kinars S,Ouchi N,Nishida M,Arita Y,Kumsda M,et al.Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice[J].Girculation,2002,106(22):2767-770.
-
8刘岩,邹大进,李慧,陈月,丁继军,郑兴,郭鹏飞.低脂联素血症是冠状动脉粥样硬化严重程度的重要标志[J].中华内分泌代谢杂志,2005,21(1):5-8. 被引量:111
-
9Nakamura y,Shimada K,Fukuda D,Shimada Y,Ehara S,Hirose M,et al.Implications of plasma concentrations of adiponectin in patients with coronary artery disease [J].Heart,2004,90(5):528-533.
-
10刘叶,于晓玲.不同类型冠心病患者血清脂联素水平及冠心病危险因素的变化[J].中国心血管病研究,2006,4(4):287-289. 被引量:19
二级参考文献31
-
1刘军,陈影,刘芳,姚庆姑,许火根,澎名淑,郭瑜琳,陈钦达.2型糖尿病家系非糖尿病一级亲属脂联素水平与胰岛素抵抗和动脉粥样硬化相关性研究[J].中华内分泌代谢杂志,2004,20(3):215-216. 被引量:30
-
2李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
-
3[1]Scherer PE,Williams S,Fogliano M,et al.A novel serum protein similar to Clq,produced exclusively in adipocytes.J Biol Chem,1995,270:26746-26749.
-
4[2]Fruebis J,Tsao TS,Javorschi S,et al.Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice.ProcNatl Acad Sci USA,2001,98:2005-2010.
-
5[3]Tomas E,Tsao TS,Saha AK,et al.Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain:acety1-CoA carboxylase inhibition and AMP-activated protein kinase activation.Proc Natl Acad Sci USA,2002,99:16309-16313.
-
6[4]Yamauchi T,Kamon J,Mizokoshi Y,et al.Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMPactivated protein kinase.Nat Med,2002,8:1258-1259.
-
7[5]Ouchi N,Kihara S,Arita Y,et al.Adipocyte derived plasma protein adiponectin,suppresses lipid accumulation and class A scavenger receptor expression in human monocyte derived macrophages.Circu-lating,2001,103:1057-1063.
-
8[7]Poulter N.Coronary heart diaease is a mulfifactorial disease.Am J Hypertens,1999,12:S92-S95.
-
9[8]Philip KG,Gregorio D,Lu T,et al.Adiponectin expression from human adipose tissue:relation to obesity,insulin resistance and tumour necrosis-αexpression.Diabetes,2003,52:1779-1785.
-
10Okamoto Y, Arita Y, Nishida M, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res, 2000,32:47-50.
共引文献128
-
1郭文昀,黄岚,苏华科,边威,宋耀明.脂联素在动脉粥样硬化中的抗炎性作用[J].岭南心血管病杂志,2009,15(5):403-406. 被引量:2
-
2苏杨,张红苗.脂联素与冠心病的研究进展[J].云南医药,2013,34(1):69-73. 被引量:5
-
3陈玲,衡先培,蓝元隆,黄苏萍,涂春香,陈燕.丹瓜方对2型糖尿病模型大鼠骨骼肌脂联素的影响[J].福建中医药大学学报,2013,23(1):10-12. 被引量:1
-
4杨铁勇,李霞.脂联素与心血管疾病的研究[J].兵团医学,2009(3):44-47.
-
5邹大进.超重和肥胖——代谢综合征的主要病因[J].国外医学(内分泌学分册),2005,25(3):145-147. 被引量:56
-
6吴玥婷,陈鲁原.动脉粥样硬化进程中脂联素的研究进展[J].岭南心血管病杂志,2005,11(6):444-446.
-
7郁志明,张笛,洪侃,薛一峰,宫玲玲,李嘉萍,陆卫红,冯健.冠心病人群血清NO、ET、hs-CRP、TNF-α和脂联素水平的相互关系[J].标记免疫分析与临床,2006,13(1):4-6. 被引量:8
-
8王丽洁,罗心平,施海明.脂联素与冠心病关系的研究进展[J].医学综述,2006,12(11):682-684. 被引量:2
-
9李晋生,李长虹,王伟,王绿娅.降脂宁抗动脉粥样硬化作用的效应机制研究[J].中医药学刊,2006,24(6):1025-1027. 被引量:3
-
10肖广辉,张蕴.脂联素与心血管疾病[J].医学综述,2006,12(13):800-802.
同被引文献55
-
1许文灿,林建才,詹勇平,林少达,林丹,陈永松.老年冠心病胰岛素抵抗与脂代谢紊乱[J].中国基层医药,2004,11(11):1297-1298. 被引量:9
-
2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
-
3王义成,袁桂莉,赵九安.冠心病患者颈动脉粥样硬化与血管内皮舒张功能的临床研究[J].河北北方学院学报(医学版),2007,24(1):9-11. 被引量:8
-
4Bulcao C, Ferreira SR, Giuffrida FM, et al. The new adipose tissue and adipocytokines [J]. Cttrr Diabetes Rev, 2006, 2 ( 1 ) : 19-28.
-
5Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin [ J ]. Science, 2005, 307 (5 708) : 426-430.
-
6Malyszko J, Malyszko JS. Pawlak K, el al. Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure [ J ]. Adv Med Sci, 2008,53(1) : 32-36.
-
7Takebayashi K, Suetsugu M, Wakabayashi S, et al. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes menitus [ J]. Metabolism, 2007, 56 (4): 451-458.
-
8Kim SR, Bae YH, Bae SK, et al. Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells [ J ]. Biochim Biopt, ys Acta, 2008, 1 783 (5) : 886-895.
-
9Adya R, Tan BK, Punn A, et al.Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced anglogenesis[J]. Cardiovoac Res, 2008, 78 (2) : 356-365.
-
10Dalai TB, Yndestad A, Skjelland M, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization [J]. Circulation, 2007, 115 (8) : 972-980.
引证文献7
-
1曹宇,肖丽,姜德建,肖坚.血浆内脏脂肪素水平与冠状动脉粥样硬化程度的相关性[J].中国动脉硬化杂志,2009,17(3):206-208. 被引量:5
-
2王援,白桦.血脂及脂联素水平与脑梗死患者预后的关系[J].陕西医学杂志,2009,38(8):1082-1083. 被引量:2
-
3单莉,洪云.糖尿病大血管病变患者血清脂联素水平及其影响因素[J].临床荟萃,2010,25(11):967-969.
-
4张艳,卢红,张萍,何蕴.急性脑梗死患者颈动脉粥样硬化斑块稳定性与血清脂联素、白介素-8水平的相关性[J].临床神经病学杂志,2012,25(3):174-176. 被引量:26
-
5郭均涛.急性脑梗死患者血清脂联素、瘦素水平与运动功能恢复的相关性研究[J].中国医师进修杂志,2013,36(1):10-12. 被引量:1
-
6陈晨,魏琴.脂联素与冠心病类型和心血管危险因素的关系[J].中国医学工程,2014,22(1):63-63.
-
7苏牟潇,陈忠伦,姚力瑛.瘦素、脂联素对进展性脑梗死的预测价值及预后的影响[J].中国医师杂志,2014,16(7):988-990. 被引量:3
二级引证文献37
-
1陈洁,杜广胜,邱强,武丽娜.急性心肌梗死患者血清内脏脂肪素水平的变化及其临床意义[J].中国动脉硬化杂志,2015,23(4):402-406. 被引量:5
-
2王璟,吴宗贵,江时森,张龙江,朱飞鹏,宫剑滨,王立军,彭永平.双源CT心周脂肪定量与冠状动脉粥样硬化病变程度的相关性[J].中国动脉硬化杂志,2009,17(10):831-834. 被引量:2
-
3王联庆,赵会元.蜂王浆冻干粉银杏胶囊对105例甘油三酯、胆固醇患者的干预作用[J].陕西中医,2010,31(2):169-170. 被引量:1
-
4郭均涛.急性脑梗死患者血清脂联素、瘦素水平与运动功能恢复的相关性研究[J].中国医师进修杂志,2013,36(1):10-12. 被引量:1
-
5李建丽.血清C反应蛋白及脂联素水平与脑梗死患者颈动脉粥样硬化的相关性研究[J].中国基层医药,2013,20(7):1060-1062. 被引量:2
-
6舒志刚,梅炳银.血浆脂联素水平对急性脑梗死患者再次脑血管事件的预测价值[J].临床神经病学杂志,2013,26(5):329-331. 被引量:3
-
7曹红,吴丹,葛艳,阎娜.急性脑梗死患者血清(浆)脂联素、诱生型一氧化氮合酶、内皮素的关系及临床意义[J].中风与神经疾病杂志,2014,31(2):139-142. 被引量:11
-
8苏牟潇,陈忠伦,姚力瑛.瘦素、脂联素对进展性脑梗死的预测价值及预后的影响[J].中国医师杂志,2014,16(7):988-990. 被引量:3
-
9任海艳,林黎明,彭芳.急性脑梗死患者血清内脂素水平的改变及其与颈动脉粥样硬化斑块形成和稳定性的关系[J].临床神经病学杂志,2014,27(5):372-373. 被引量:15
-
10姜晓.血清白细胞介素-18与C-反应蛋白在急性脑梗死患者中的检测意义[J].中国实用医刊,2014,41(23):104-105. 被引量:1
-
1赵理梅,杨保胜,丰慧根.652例消化性溃疡与遗传及其它因素关系的分析[J].新乡医学院学报,1994,11(3):318-319.
-
2季菊珍,王慧珠.糖尿病肾病与血脂等相关因素关系的探讨[J].浙江省医学科学院学报,2000,11(4):25-26.
-
3张博,张黎军.视黄醇结合蛋白4与代谢综合征关系的研究进展[J].武汉大学学报(医学版),2011,32(2):277-280. 被引量:5
-
4郭妍,卢妙,程蕴琳.老年冠心病患者脂联素和内皮素的变化特点[J].中华老年医学杂志,2007,26(7):516-517.
-
5彭英兰,高锦团.脂联素与系统性红斑狼疮[J].医学综述,2008,14(11):1667-1669.
-
6彭艳,郑浩,马祥铭,费松柏.原发性高血压患者血清脂联素水平影响因素分析[J].浙江临床医学,2012,14(9):1123-1124.
-
7张福燕,李志敏,李健阳,时立新,张巧,李红,赫晓燕,唐丽.糖尿病视网膜病变与全身多因素关系[J].现代预防医学,2006,33(12):2475-2476. 被引量:8
-
8赵水平,张大庆,周宏年,聂赛,李全忠.阿托伐他汀对脂肪细胞分泌白细胞介素-6的影响[J].中华内科杂志,2003,42(12):874-875. 被引量:8
-
9韦秀英,胡世红,庞媛尹.脂联素与2型糖尿病及其大血管并发症[J].华夏医学,2004,17(4):657-658.
-
10脂肪细胞分泌TNF-α的胰岛素抵抗性作用[J].日本医学介绍,1999,20(1):32-33.